We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Medical

Quin

Status: Extended

Mar 2nd 2020 - Mar 26th 2020

Quin is a mobile medical app that combines daily life experience with data from diabetes devices and phones and helps people decide how much insulin to take and when. They are on a mission to help people with insulin-treated diabetes make the best possible decisions through their app. The company have received a UK research and innovation grant. Apple has granted them insider access to their engineers and executives who are helping to get Quin to market, their app has a class I CE Mark, with two patents pending. With the investment, they will hire a product designer to enhance the user experience, achieve certification and compliance with new European Medical Device Regulations, develope B2B2C distribution partnerships and launch the Quin app in the UK and Europe in late 2020.

read more read less

Quin Rating Review

Pitch rating powered by CROWDRATING

Rated on 15/03/2020

Pitch Rated

48%

Insufficient Data

Management

70%

Product

74%

Investment

UNRATED*

* Section unrated owing to insufficient or incomplete information available at the time of rating.

Log in to view amount pledged

    Log in to view target

    £6,753,763
    pre-money valuation

    8.16%
    equity available

    260
    investors

    £2,660
    pledge per investor

    09206022
    company number

    Liquidation
    company status

    05/09/2014
    incorporated 10 years

    Previous Funding rounds
    21 Apr 24 Seedrs £691,497 / 48.00%

What the ratings mean

  • 49% and under
    We suggest potential investors carry out further study of their own
    50-64%
    Room for improvement
    65-79%
    Worth considering
    80%+
    Gold rating, our highest rating

RISK WARNING - The ratings are based on the information provided in the fund raiser’s pitch deck, business plans and financial forecasts which have appeared on a FCA regulated crowdfunding site. Where possible we validate the business plan to public sources such as LinkedIn, Companies House, Credit Agencies and internet searches. We cannot guarantee the information is correct. The ratings report takes no account of the investors/ individual circumstances. Do your own due diligence and get professional advice before investing. Your capital is at risk when investing in private companies.

Login to view the full report

Management 70%

Skills 73%
The founders have a deep entrepreneurial and technical background. One of the founders has led teams across several countries and the other founder is a robotics engineer who has been living with diabetes for 26 years. They are backed by a skilled team of twelve members who have expertise in covering the functional areas of sales, marketing, operations, human-centered design thinking, leadership, culture, and compliance. The founders have been working in the company for over five years. However, the company lacks a dedicated head of finance.

0 comments

Log in to comment


Funding progress

Log in to view funding progress.


Log in to view amount pledged

    Log in to view target

    £6,753,763
    pre-money valuation

    8.16%
    equity available

    260
    investors

    £2,660
    pledge per investor

    09206022
    company number

    Liquidation
    company status

    05/09/2014
    incorporated 10 years

    Previous Funding rounds
    21 Apr 24 Seedrs £691,497 / 48.00%
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph